Found: 175
Select item for more details and to access through your institution.
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Retinal Nerve Fiber Layer Thinning in CADASIL: An Optical Coherence Tomography and MRI Study.
- Published in:
- Cerebrovascular Diseases, 2010, v. 31, n. 1, p. 77, doi. 10.1159/000321339
- By:
- Publication type:
- Article
Plasma Levels of Asymmetric Dimethylarginine in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy.
- Published in:
- Cerebrovascular Diseases, 2008, v. 26, n. 6, p. 636, doi. 10.1159/000166840
- By:
- Publication type:
- Article
Impact of Hypothermic Oxygenated Machine Perfusion on Hepatocellular Carcinoma Recurrence after Liver Transplantation.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 5, p. 703, doi. 10.3390/jpm13050703
- By:
- Publication type:
- Article
Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2374, doi. 10.3390/cancers16132374
- By:
- Publication type:
- Article
Imaging brain damage in first‐degree relatives of sporadic and familial multiple sclerosis.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 4, p. 634
- By:
- Publication type:
- Article
N-acetylaspartate: usefulness as an indicator of viable neuronal tissue.
- Published in:
- 2001
- By:
- Publication type:
- commentary
Oxidative phosphorylation defect in the brains of carriers of the tRNA<sup>leu(UUR)</sup> A3243G mutation in a MELAS pedigree.
- Published in:
- Annals of Neurology, 2000, v. 47, n. 2, p. 179, doi. 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
- By:
- Publication type:
- Article
In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using <sup>1</sup>H magnetic resonance spectroscopic imaging.
- Published in:
- Annals of Neurology, 1998, v. 44, n. 2, p. 273, doi. 10.1002/ana.410440222
- By:
- Publication type:
- Article
Chemical pathology of acute demyelinating lesions and its correlation with disability.
- Published in:
- Annals of Neurology, 1995, v. 38, n. 6, p. 901, doi. 10.1002/ana.410380610
- By:
- Publication type:
- Article
APOE ε2 is associated with white matter hyperintensity volume in CADASIL.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2016, v. 36, n. 1, p. 199, doi. 10.1038/jcbfm.2015.85
- By:
- Publication type:
- Article
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.585296
- By:
- Publication type:
- Article
Fractal dimension of the cortical gray matter outweighs other brain MRI features as a predictor of transition to dementia in patients with mild cognitive impairment and leukoaraiosis.
- Published in:
- Frontiers in Human Neuroscience, 2023, p. 01, doi. 10.3389/fnhum.2023.1231513
- By:
- Publication type:
- Article
A double‐blind, randomized, placebo‐controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing‐remitting multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 7, p. 977, doi. 10.1002/acn3.51574
- By:
- Publication type:
- Article
Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 3, p. 623, doi. 10.1002/acn3.51302
- By:
- Publication type:
- Article
The Role of TNF-α in Alzheimer's Disease: A Narrative Review.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 1, p. 54, doi. 10.3390/cells13010054
- By:
- Publication type:
- Article
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 19, p. 2383, doi. 10.3390/cells12192383
- By:
- Publication type:
- Article
Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 12, p. 1708, doi. 10.3390/brainsci12121708
- By:
- Publication type:
- Article
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 44, doi. 10.1177/13524585231212879
- By:
- Publication type:
- Article
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2212, doi. 10.1177/13524585221118677
- By:
- Publication type:
- Article
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1881, doi. 10.1177/13524585221096975
- By:
- Publication type:
- Article
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 885, doi. 10.1177/13524585211045545
- By:
- Publication type:
- Article
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 154, doi. 10.1177/13524585211019650
- By:
- Publication type:
- Article
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 111, doi. 10.1177/13524585211010294
- By:
- Publication type:
- Article
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 39, doi. 10.1177/1352458519900972
- By:
- Publication type:
- Article
Response to Dr Boyko's letter: 'Radiologically isolated syndrome with oligoclonal bands in CSF (RIS + OCB) can be classified as highly MS-risk group'.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 4, p. 476, doi. 10.1177/1352458519837707
- By:
- Publication type:
- Article
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 541, doi. 10.1177/1352458517742739
- By:
- Publication type:
- Article
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 217, doi. 10.1177/1352458517743804
- By:
- Publication type:
- Article
Response to ‘Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?’ by Schiffmann et al.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 2, p. 214, doi. 10.1177/1352458517717808
- By:
- Publication type:
- Article
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 2, p. 222, doi. 10.1177/1352458517690269
- By:
- Publication type:
- Article
Imaging outcome measures for progressive multiple sclerosis trials.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 14, p. 1614, doi. 10.1177/1352458517729456
- By:
- Publication type:
- Article
Imaging outcome measures for progressive multiple sclerosis trials.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 12, p. 1614, doi. 10.1177/1352458517729456
- By:
- Publication type:
- Article
Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials - Commentary.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 656, doi. 10.1177/1352458516659550
- By:
- Publication type:
- Article
Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 10, p. 1297, doi. 10.1177/1352458515616701
- By:
- Publication type:
- Article
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 7, p. 894, doi. 10.1177/1352458514555786
- By:
- Publication type:
- Article
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: Yes.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 537, doi. 10.1177/1352458514526084
- By:
- Publication type:
- Article
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 3, p. 280, doi. 10.1177/1352458513507360
- By:
- Publication type:
- Article
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 214, doi. 10.1177/1352458513494490
- By:
- Publication type:
- Article
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 4, p. 411, doi. 10.1177/1352458512457721
- By:
- Publication type:
- Article
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 3, p. 257, doi. 10.1177/1352458512460418
- By:
- Publication type:
- Article
Modelling the distribution of cortical lesions in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 2, p. 229, doi. 10.1177/1352458511414965
- By:
- Publication type:
- Article
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 5, p. 541, doi. 10.1177/1352458510391837
- By:
- Publication type:
- Article
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 3, p. 319, doi. 10.1177/1352458510388824
- By:
- Publication type:
- Article
Magnetic Resonance Imaging Evidence Supporting the Efficacy of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis.
- Published in:
- CNS Drugs, 2024, v. 38, n. 4, p. 267, doi. 10.1007/s40263-024-01074-3
- By:
- Publication type:
- Article
Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article